Amneal Pharmaceutical announced that it has been added to the S&P SmallCap 600 Index. The inclusion will become effective prior to the opening of trading on Friday, January 30.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMRX:
- Amneal Finalizes Nationwide Opioid Settlement Implementation Plan
- Closing Bell Movers: Texas Instruments up 8%, F5 up 11% on earnings
- Amneal Pharmaceuticals to replace TTM Technologies in S&P 600 at open on 1/30
- Amneal Pharmaceuticals Files Routine Regulation FD Disclosure Report
- Amneal Pharmaceuticals, KeifeRx enter research collaboration, option agreement